KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026)
KORU Medical Systems' (KRMD) quarterly Liabilities and Shareholders Equity came in at $28.6 million in Q1 2026, up 5.05% year-on-year from $27.2 million in Q1 2025, and up 1.39% on a QoQ basis from $28.2 million in Q4 2025.
KORU Medical Systems (KRMD) Liabilities and Shareholders Equity (2011 - 2026) Analysis & Trends
KORU Medical Systems (KRMD) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $28.6 million in Q1 2026.
- On a quarterly basis, Liabilities and Shareholders Equity rose 5.05% year-over-year to $28.6 million in Q1 2026; TTM through Mar 2026 was $109.4 million, a 0.26% change from a year earlier, with the FY2025 full-year figure at $28.2 million, up 3.61% from the prior year.
- Liabilities and Shareholders Equity for Q1 2026 stood at $28.6 million, up from $28.2 million in the prior quarter.
- Over the last five years, Liabilities and Shareholders Equity for KRMD reached as high as $43.4 million in Q1 2022 and fell as low as $25.5 million in Q2 2025.
- Historically, Liabilities and Shareholders Equity has averaged $32.6 million across 5 years, with a median of $28.5 million in 2023.
- Across the five-year window, Liabilities and Shareholders Equity tumbled 32.77% in 2023 and gained 5.05% in 2026, its largest moves.
- Year by year, Liabilities and Shareholders Equity stood at $42.3 million in 2022, then tumbled by 32.77% to $28.5 million in 2023, then fell by 4.37% to $27.2 million in 2024, then gained by 3.61% to $28.2 million in 2025, then grew by 1.39% to $28.6 million in 2026.
- Per Business Quant data, the three most recent Liabilities and Shareholders Equity figures were $28.6 million in Q1 2026, $28.2 million in Q4 2025, and $27.1 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Alcon | 32,734,969.19 Bn | 32,734,967.53 Bn | 1.53 Bn | 31.62 Bn |
| 2 | Intuitive Surgical | 117.50 Bn | 112.41 Bn | 1.96 Bn | 20.88 Bn |
| 3 | Becton Dickinson | 42.93 Bn | 42.11 Bn | 2.15 Bn | 50.83 Bn |
| 4 | Medline | 30.82 Bn | 36.66 Bn | 1.84 Bn | 39.01 Bn |
| 5 | Resmed | 27.90 Bn | 26.23 Bn | 890.98 Mn | 8.78 Bn |
| 6 | West Pharmaceutical Services | 26.76 Bn | 26.23 Bn | 329.20 Mn | 4.08 Bn |
| 7 | Cooper Companies | 15.30 Bn | 15.16 Bn | 735.40 Mn | 12.48 Bn |
| 8 | Solventum | 13.46 Bn | 12.90 Bn | 1.10 Bn | 14.10 Bn |
| 9 | Align Technology | 12.02 Bn | 10.96 Bn | 736.59 Mn | 6.31 Bn |
| 10 | KORU Medical Systems | 172.94 Mn | 164.14 Mn | 7.23 Mn | 28.59 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 28.59 Mn |
| Dec 31, 2025 | 28.20 Mn |
| Sep 30, 2025 | 27.10 Mn |
| Jun 30, 2025 | 25.52 Mn |
| Mar 31, 2025 | 27.22 Mn |
| Dec 31, 2024 | 27.22 Mn |
| Sep 30, 2024 | 27.39 Mn |
| Jun 30, 2024 | 27.30 Mn |
| Mar 31, 2024 | 27.50 Mn |
| Dec 31, 2023 | 28.46 Mn |
| Sep 30, 2023 | 35.35 Mn |
| Jun 30, 2023 | 36.00 Mn |
| Mar 31, 2023 | 38.25 Mn |
| Dec 31, 2022 | 42.33 Mn |
| Sep 30, 2022 | 42.67 Mn |
| Jun 30, 2022 | 42.46 Mn |
| Mar 31, 2022 | 43.43 Mn |
| Dec 31, 2021 | 41.29 Mn |
| Sep 30, 2021 | 41.36 Mn |
| Jun 30, 2021 | 40.60 Mn |